SCHEMBL31346248

SCHEMBL31346248

Nc1nc2nc3ccccc3n2cc1Cc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 5/20 0.59
ADORA1 P30542 3/20 0.59
PTPN1 P18031 1/20 0.48
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
LMNA P02545 4/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
NPSR1 Q6W5P4 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
ALDH1A1 P00352 2/20 0.39
ADORA2B P29275 1/20 0.39
MAPT P10636 2/20 0.38
HTT P42858 2/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12165674 0.74 ADORA2A (0.89) ADORA2AADORA1PTPN1MAOAMAOB
SCHEMBL11823273 0.69 ALDH1A1 (0.50) ADORA2AADORA1PTPN1LMNAMEN1
SCHEMBL11195391 0.68 ADORA2A (0.43) ADORA2AADORA1PTPN1LMNAMEN1
SCHEMBL3207917 0.67 TLR8 (0.57) LMNAKMT2AALDH1A1MAPTKDM4E
SCHEMBL10575256 0.67 BCL2 (0.48) CYP3A4
SCHEMBL14478942 0.66 KDM4E (0.50) ADORA2AADORA1NPSR1CYP1A2CYP3A4
SCHEMBL9409256 0.66 LTB4R (0.45) ADORA2AADORA1
SCHEMBL12165801 0.66 ADORA2A (0.67) ADORA2AADORA1PTPN1MAOAMAOB
SCHEMBL21223649 0.66 CYP3A4 (0.46) ADORA1LMNAMEN1KMT2ACYP1A2
SCHEMBL22633448 0.65 RAD51 (0.45) ADORA2AADORA1PTPN1SMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114423763-B Regioselective synthesis of imidazo [1,2-a ] pyrimidines 豪夫迈·罗氏有限公司 2025-01-21 CN disclosed